- Home
- GES vs RAPP Comparison
GES vs RAPP Comparison
Compare GES & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GES
- RAPP
- Stock Information
- Founded
- GES 1981
- RAPP 2022
- Country
- GES Switzerland
- RAPP United States
- Employees
- GES N/A
- RAPP N/A
- Industry
- GES Apparel
- RAPP
- Sector
- GES Consumer Discretionary
- RAPP
- Exchange
- GES Nasdaq
- RAPP Nasdaq
- Market Cap
- GES 567.6M
- RAPP 463.8M
- IPO Year
- GES 1996
- RAPP 2024
- Fundamental
- Price
- GES $12.11
- RAPP $9.63
- Analyst Decision
- GES Buy
- RAPP Strong Buy
- Analyst Count
- GES 4
- RAPP 5
- Target Price
- GES $17.75
- RAPP $35.00
- AVG Volume (30 Days)
- GES 1.1M
- RAPP 117.4K
- Earning Date
- GES 05-29-2025
- RAPP 05-08-2025
- Dividend Yield
- GES 10.02%
- RAPP N/A
- EPS Growth
- GES N/A
- RAPP N/A
- EPS
- GES 0.77
- RAPP N/A
- Revenue
- GES $2,995,273,000.00
- RAPP N/A
- Revenue This Year
- GES $4.77
- RAPP N/A
- Revenue Next Year
- GES $3.09
- RAPP N/A
- P/E Ratio
- GES $15.62
- RAPP N/A
- Revenue Growth
- GES 7.88
- RAPP N/A
- 52 Week Low
- GES $8.48
- RAPP $6.43
- 52 Week High
- GES $27.41
- RAPP $29.74
- Technical
- Relative Strength Index (RSI)
- GES 59.81
- RAPP N/A
- Support Level
- GES $10.59
- RAPP N/A
- Resistance Level
- GES $12.85
- RAPP N/A
- Average True Range (ATR)
- GES 0.45
- RAPP 0.00
- MACD
- GES 0.14
- RAPP 0.00
- Stochastic Oscillator
- GES 68.83
- RAPP 0.00
About GES Guess? Inc.
Guess? Inc designs, markets distributes, and licenses contemporary apparel and accessories that reflect European fashion sensibilities and American Lifestyle under brands including Guess, Marciano, and G by Guess. The company has five reportable segments: Americas Retail, Americas Wholesale, Europe, Asia, and licensing. Geographically, the company derives maximum revenue from the United States.
About RAPP Rapport Therapeutics Inc. Common Stock
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.